Abstract
Increasing amounts of porcine secretion (0.05 to 2.00 clinical units/h/100 g body wt) given to rats during a continuous infusion of bilirubin, increased bile flow and the apparent maximal biliary excretion of bilirubin ('Tm'). This increment was caused by an enhanced biliary output of bilirubin monoconjugates. The effect was dose dependent but maximal at a secretin infusion of 0.80 CU. Somatostatin 0.2 and 0.8 microgram/h/100 g body wt caused a dose related inhibition of the hepatic effects of secretin both on bile flow and on biliary output of bilirubin conjugates. As secretin elicits the release of somatostatin, a feed-back system could be envisaged whereby the somatostatin released stops the effects of secretin.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berelowitz M., Kronheim S., Pimstone B., Shapiro B. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose. J Clin Invest. 1978 May;61(5):1410–1414. doi: 10.1172/JCI109059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fahrenkrug J. Vasoactive intestinal polypeptide. Clin Gastroenterol. 1980 Sep;9(3):633–643. [PubMed] [Google Scholar]
- Fevery J., Van Damme B., Michiels R., De Groote J., Heirwegh K. P. Bilirubin conjugates in bile of man and rat in the normal state and in liver disease. J Clin Invest. 1972 Sep;51(9):2482–2492. doi: 10.1172/JCI107062. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Forker E. L., Hicklin T., Sornson H. The clearance of mannitol and erythritol in rat bile. Proc Soc Exp Biol Med. 1967 Oct;126(1):115–119. doi: 10.3181/00379727-126-32380. [DOI] [PubMed] [Google Scholar]
- Ipp E., Dobbs R. E., Harris V., Arimura A., Vale W., Unger R. H. The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas. J Clin Invest. 1977 Nov;60(5):1216–1219. doi: 10.1172/JCI108875. [DOI] [PMC free article] [PubMed] [Google Scholar]
- René E., Danzinger R. G., Hofmann A. F., Nakagaki M. Pharmacologic effect of somatostatin on bile formation in the dog. Enhanced ductular reabsorption as the major mechanism of anticholeresis. Gastroenterology. 1983 Jan;84(1):120–129. [PubMed] [Google Scholar]
- Ricci G. L., Fevery J. Cholestatic action of somatostatin in the rat: effect on the different fractions of bile secretion. Gastroenterology. 1981 Sep;81(3):552–562. [PubMed] [Google Scholar]
- Ricci G. L., Fevery J. Stimulation by secretin of bilirubin UDP-glycosyltransferase activities and of cytochrome P-450 concentration in rat liver. Biochem J. 1979 Sep 15;182(3):881–884. doi: 10.1042/bj1820881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ricci G. L., Fevery J. The action of VIP on bile secretion and bile acid output in the non-anaesthetized rat. Biochem Pharmacol. 1985 Oct 15;34(20):3765–3767. doi: 10.1016/0006-2952(85)90243-6. [DOI] [PubMed] [Google Scholar]
- Ricci G. L., Michiels R., Fevery J., De Groote J. Enhancement by secretin of the apparently maximal hepatic transport of bilirubin in the rat. Hepatology. 1984 Jul-Aug;4(4):651–657. doi: 10.1002/hep.1840040414. [DOI] [PubMed] [Google Scholar]
- Schusdziarra V., Harris V., Unger R. H. Half-life of somatostatin-like immunoreactivity in canine plasma. Endocrinology. 1979 Jan;104(1):109–110. doi: 10.1210/endo-104-1-109. [DOI] [PubMed] [Google Scholar]
- Van Roy F. P., Heirwegh K. P. Determination of bilirubin glucuronide and assay of glucuronyltransferase with bilirubin as acceptor. Biochem J. 1968 Apr;107(4):507–518. doi: 10.1042/bj1070507. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WEINBREN K., BILLING B. H. Hepatic clearance of bilirubin as an index of cellular function in the regenerating rat liver. Br J Exp Pathol. 1956 Apr;37(2):199–204. [PMC free article] [PubMed] [Google Scholar]